Please use a minimum of three unique search wordsOur search is configured to only display links relevant to answer your question. For the best results please use specific and relevant keywords that accurately reflect the information you are seeking.Please do not use this field to report adverse events or product complaints. Adverse events and product complaints should be reported. Reporting forms and information can be found at UK: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. Adverse events and product complaints should also be reported to Lilly: please call Lilly UK on 01256 315 000.
Trulicity ® (dulaglutide)
Trulicity® (dulaglutide): Use with COVID-19 Vaccines
The use of vaccines against SARS-CoV-2 in patients treated with dulaglutide has not been studied.
COVID-19 is an infectious respiratory disease caused by SARS-CoV-2, previously referred to as "2019 novel coronavirus."1
The use of a SARS-CoV-2 vaccine in patients treated with dulaglutide has not been studied by Lilly.
Decisions regarding the use of any vaccination, including SARS-CoV-2 vaccines, in patients treated with dulaglutide should be made at the discretion of the prescribing physician using their best clinical judgment, and must be made by the clinician after careful consideration of risk factors of the patient as well as the risks and benefits of vaccination. Consultation with an infectious disease expert may be helpful in high-risk or emergency situations such as the current COVID-19 pandemic.
Possible impact of vaccination on blood glucose concentration
The International Diabetes Federation IDF states that after any vaccination the blood glucose levels might rise for a few days.2
Further resources on COVID-19 Vaccines and Diabetes
For information on COVID-19 vaccines and diabetes, please refer to
Diabetes & Coronavirus Vaccination on the IDF website. 2
For current information on COVID-19 and COVID-19 vaccines in gereral, please refer to
Coronavirus disease (COVID-19) outbreak on the regional office EU WHO, and
1. Naming the coronavirus disease (COVID-19) and the virus that causes it. World Health Organization. Accessed March 17, 2020. https://www.who.int/emergencies/diseases/novel-coronavirus-2019/technical-guidance/naming-the-coronavirus-disease-(covid-2019)-and-the-virus-that-causes-it
2. International Diabetes Federation Europe. Diabetes & Coronavirus Vaccination. https://idf.org/our-network/regions-members/europe/europe-news/370-diabetes-coronavirus-vaccination.html. Accessed April 29, 2021
3. Coronavirus disease (COVID-19) outbreak. European web page of the World Health Organization. Accessed March 20, 2020. http://www.euro.who.int/en/health-topics/health-emergencies/coronavirus-covid-19
4. COVID-19. European Centre for Disease Prevention and Control. Accessed March 20, 2020. https://www.ecdc.europa.eu/en/novel-coronavirus-china
Glossary
COVID-19 = coronavirus disease 2019
ECDC = European Centre for Disease Prevention and Control
EU WHO = World Health Organization (European regional office)
IDF = International Diabetes Federation
Lilly = Eli Lilly and Company
SARS-CoV-2 = severe acute respiratory syndrome coronavirus 2
Date of Last Review: January 12, 2021
Contact Lilly
Call or Email us
If you want to ask a Medical Information question or you want to report an adverse event or product complaint you can call us or email us at ukmedinfo@lilly.com
Available Mon - Fri, 10am - 4pm, excluding Bank Holidays